Addiction and pregnancy

Heroin Addiction and Related Clinical Problems

Volumn 7, Issue 4, 2005, Pages 5-21

  Finnegan, Loretta P ^a   Amass, Leslie ^b   Jones, Hendree ^c   Kaltenbach, Karol ^d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b FRIENDS RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Addiction; Buprenorphine; Methadone; Pregnancy

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; DIAMORPHINE; METHADONE; MORPHINE; MORPHINE DERIVATIVE; PLACEBO;

ADDICTION; BEHAVIOR THERAPY; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG OVERDOSE; DRUG SAFETY; HUMAN; INFANT DISEASE; INFANT MORTALITY; LOW BIRTH WEIGHT; MATERNAL MORBIDITY; METHADONE TREATMENT; NEWBORN INTENSIVE CARE; OPIATE ADDICTION; PATIENT COMPLIANCE; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; RISK ASSESSMENT; SOCIAL PSYCHOLOGY; WITHDRAWAL SEIZURE; WITHDRAWAL SYNDROME;

EID: 30444456697     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. th Annual Meeting of the College on Problems of Drug Dependence, Bal Harbour, Florida.
2. AMERICAN ACADEMY OF PEDIATRICS (1998): Neonatal drug withdrawal. Pediatrics 101: 1079-1088.
3. AURIACOMBE M., AFFLELOU S., LAVIGNASSE P., LAFITTE C., ROUX D., DAULOUÉDE J.P., TIGNOL J. (1999): Pregnancy, abortion, and delivery in a cohort of heroin-addicted subjects undergoing substitution treatment (methadone and buprenorphine) in aquitaine. La Presse Médicale 28: 177.
4. BERGHELLA V., LIM P.J., HILL M.K., CHERPES J., CHENNAT B., KALTENBACH K. (2003): Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol 189(2): 312-17.
5. BICKEL W.K., AMASS L., HIGGINS S.T., BADGER G.J., ESCH R.A. (1997): Effects of adding behavioral treatment to opioid detoxification with buprenorphine. J Consult Clin Psychol 65(5): 803-810.
6. BLINICK G., JEREZ E., WALACH R.C. (1973): Methadone maintenance, pregnancy, and progeny. JAMA 225: 477-479.
7. BROWN H.L., BRITTON K.A., MAHAFFEY D., BRIZENDINE E., HIETT A.K., Turnquest M.A. (1998): Methadone maintenance in pregnancy: a reappraisal. Am J Obstet Gynecol 179: 459-463.
8. CARROLL, K.M., CHANG, G., BEHR, H.M., CLINTON, B., KOSTEN, T.R. (1995): Improving treatment outcome in pregnant, methadone-maintained women: results from a randomized clinical trial. American Journal on Addictions 4: 56-59.
9. CENTER FOR SUBSTANCE ABUSE TREATMENT (1994): Practical approaches in the treatment of women who abuse alcohol and other drugs. U.S. Department of Health and Human Services, Rockville, MD.
10. CENTER FOR SUBSTANCE ABUSE TREATMENT, CONSENSUS PANEL Chair, Mitchell J.L. (1993): Treatment improvement protocol for pregnant substance-using women. U.S. Department of Health and Human Services, Rockville, MD.
11. CENTER FOR SUBSTANCE ABUSE TREATMENT, CONSENSUS PANEL Chair, Kandall, S.R. (1993a): Treatment improvement protocol: improving treatment for drug-exposed infants. U.S. Department of Health and Human Services, Rockville, MD.
12. CHANG, G., CARROLL, K.M., BEHR, H.M., KOSTEN, T.R. (1992): Improving treatment outcome in pregnant opiate-dependent women. J Subst Abuse Treat 9(4): 327-330.
13. DASHE J.S., SHEFFIELD J.S., OLSCHER D.A., TODD S.J., JACKSON G.L., WENDEL G.D. (2002): Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecology 100(6): 1244-1249.
14. DOBERCZAK T., KANDALL S., FRIEDMAN R.P. (1993): Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecology 81: 963.
15. DOBERCZAK T., KANDALL S., WILETS I. (1991): Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 118: 933-937.
16. DOLE V.P., NYSWANDE, M.E. (1966): Rehabilitation of heroin addicts after blockade with methadone. NY State J Med 66 (15): 2011-2017.
17. DROZDICK J., BERGHELLA V., HILL K., KALTENBACH K. (2002): Methadone trough levels in pregnancy. Am J Obstet Gynecol 187: 1184-1118.
18. ELK R., SCHMITZ J., SPIGA R., RHOADES H., ANDRES R., GRABOWSKI J. (1995): Behavioral treatments of cocaine-dependent women and TB-exposed patients. Addict Behav 20: 533-542.
19. FINNEGAN L.P. (1991): Treatment issues for opioid dependent women during the perinatal period. J Psychoactive Drugs 23(2): 191-202.
20. FINNEGAN, L.P., HAGAN, T., KALTENBACH, K.A. (1991): Scientific foundation of clinical practice: opiate use in pregnant women. Bull, NY Acad Med 67(3): 223-239.
21. FINNEGAN, L.P., KALTENBACH, K. (1992): Neonatal abstinence syndrome. In Hoekelman R.A., Nelson N.M., Eds: Primary Pediatric Care. 2nd ed. Mosby Yearbook, St. Louis, MO. pp. 1367-1378.
22. FINNEGAN, L.P., KALTENBACH, K.A., PASTO, M., ET AL. (1984): Improving outcome of children born to drug dependent mothers. In Call, J., Galenson, E., Tyson, R., Eds.: Frontiers of Infant Psychiatry (Vol II). Basic Books, New York, pp 225-231.
23. FINNEGAN, L.P., KANDALL, S.R. (1992): Maternal and neonatal effects of alcohol and drugs. In Lowinson, J., Ruiz, P., Millman, R., Eds.: Substance Abuse: A Comprehensive Textbook. Williams & Wilkins, Baltimore, pp. 628-656.
24. FINNEGAN L.P., KANDALL S.R. (1997): Maternal and neonatal effects of alcohol and drugs. In Lowinson J.H., Ruiz P., Millman R.B., Langrod J.G., Eds.: Substance Abuse: A Comprehensive Textbook (Third Edition). Williams & Wilkins, Baltimore, MD. pp 513-534.
25. FUDALA P.J., JAFFE J.H., DAX E.M., JOHNSON R.E. (1990): Use of buprenorphine in the treatment of opiate addiction: II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther 47: 525-534.
26. HAGOPIAN G.S., WOLFE H.M., SOKOL R.J., AGER J.W., WARDELL J.N., CEPEDA E.E. (1996): Neonatal outcomes following methadone exposure in utero. J Matern Fetal Med 5: 348-54.
27. HARPER R., SOLISH G., FEINGOLD E., GERSTEIN-WOLF N., SOKAL M. (1977): Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome. Am J Obstet Gynecol 129: 417-24.
28. HERZLINGER R.A., KANDALL S.R., VAUGHAN H.G. (1977): Neonatal seizures associated with narcotic withdrawal. J Pediatr 91: 638-641.
29. HIGGINS, S.T., SILVERMAN, K., EDS. (1999): Motivating Behavior Change Among Illicit-Drug Abusers: Contemporary Research on Contingency Management Interventions. American Psychological Association, Washington, DC.
30. HIGGINS, S.T., HEIL, S.H., SOLOMON, L.J., BERNSTEIN, I.M., LUSSIER, J.P., ABEL, R.L., LYNCH, M.E., BADGER, G.J. (2004): A pilot study on voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum. Nicotine Tob Res, 6 (6): 1015-1020.
31. HIGGINS, S.T., PETRY, N.M. (1999): Contingency management, incentives for sobriety. Alcohol Research and Health 23(2): 122-127.
32. IGUCHI, M.Y., BELDING, M.A., MORRAL, A.R., LAMB, R.J., HUSBAND, S.D. (1997): Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. J Consult Clin Psychol 65: 421-428.
33. JARVIS M.A., SCHNOLL S.H. (1994): Methadone treatment during pregnancy. J Psychoactive Drugs 26: 155-161.
34. JASINSKI D.R., PEVNICK J.S., GRIFFITH J.D. (1978): Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen Psych 35: 501-16.
35. JOHNSON R.E., JONES H.E., FISCHER G. (2003): Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend 79: S87-S101.
36. JONES H.E., JOHNSON R.E., JASINSKI D.R., MILIO L. (2005): Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Drug Alcohol Depend 78(1): 33-38.
37. JONES, H.E., HAUG, N., SILVERMAN, K., STITZER, M., SVIKIS, D. (2001): The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug Alcohol Depend 61: 297-306.
38. JONES, H.E., HAUG, N.A., STITZER, M.L., SVIKIS, D.S. (2000): Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives. Addict Behav, 25(2): 263-267.
39. KALTENBACH K., BERGHELLA V., FINNEGAN L. (1998): Opioid dependence during pregnancy: effects and management. Obstetr Gynecol Clin North Am 25: 139-151.
40. KALTENBACH K., COMFORT M.L. (1997): Methadone maintenance of greater than 80 mg during pregnancy. NIDA Res Monogr 174: 128.
41. KALTENBACH K., FINNEGAN L.P. (1989): Prenatal narcotic exposure: perinatal and developmental effects. Neurotoxicology 10: 597-604.
42. KALTENBACH K., SILVERMAN N.. WAPNER R.J. (B 1992): Methadone maintenance during pregnancy. In State Methadone Treatment Guidelines, Center for Substance Abuse Treatment. U.S. Department of Health and Human Services, Rockville, MD. pp 85-93.
43. KANDALL S., DOBERCZAK T., JANTUNEN M., STEIN J. (1999): The methadone maintained pregnancy. Clin Perinatol 26: 173-183.
44. KANDALL S.R., ALBIN S., GARTNER L.M., LEE K., EIDELMAN A., LOWINSON J. (1977): The narcotic dependent mother: fetal and neonatal consequences. Early Hum Dev 1: 159-169.
45. KANDALL S.R., DOBERCZAK T.M., MAUER K.R., STRASHUN R.H., KORTS D.C. (1983): Opiate v CNS depressant therapy in neonatal drug abstinence syndrome. Am J Dis Child 137: 378-82.
46. KIDORF, M., HOLLANDER, J.R., KING, V.L., BROONER, R.K. (1998): Increasing employment of opioid dependent outpatients: an intensive behavioral intervention. Drug Alcohol Depend 50(1): 73-80.
47. KREEK M.J. (1987): Opiate ethanol interactions: implications for the biological basis and treatment of combined addictive diseases. NIDA Res Monogr 81: 428-439.
48. LEJEUNE C., AUBISSON S., SIMMAT-DURAND L., CNEUDE F., PIQUET M., GOURARIER L. (2001): Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases. Annales de Medecine Interne 152: 2S21-2S27.
49. LITTLE, B.B., SNELL, L.M., GILSTRAP, L.D., JOHNSTON, W.L. (1990): Patterns of multiple substance abuse during pregnancy: implications for mother and fetus. So Med J 83: 507-518.
50. MADDEN J., CHAPPEL J., ZUSPAN F., GUMPEL J., MEJIA A., DAVIS R. (1977): Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol 127: 199-201.
51. MALPAS T.J., DARLOW B.A., LENNOX R., HORWOOD L.J. (1995): Maternal methadone dosage and neonatal withdrawal. Aust NZ J Obstet Gynecol 35: 175-7.
52. MARTIN W.R., EADES C.G., THOMPSON J.A., HUPPLER R.E., GILBERT P.E. (1976): The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197: 517-32.
53. MAYES L.C., CARROLL K.M. (1996): Neonatal withdrawal syndrome in infants exposed to cocaine and methadone. Subst Use Misuse 31: 241-53.
54. th Anniversary National Conference, Orlando, Florida.
55. MCCARTHY J.J., POSEY B.L.: (2000): Methadone levels in human milk. J Hum Lact 16: 115-120.
56. MELLO N.K., MENDELSON J.H. (1980): Buprenorphine suppresses heroin use by heroin addicts. Science 207: 657-659.
57. MENDELSON J., JONES R.T. (2003): Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? Drug Alcohol Depend 70: S29-S37.
58. NATIONAL INSTITUTES OF HEALTH CONSENSUS DEVELOPMENT PANEL (1998): Effective medical treatment of opiate addiction. JAMA 280(22): 1936-1943.
59. NEWMAN R.G., BASHKOW S., CALKO D. (1974): Results of 313 consecutive live births of infants delivered to patients in the New York City methadone maintenance treatment program. Am J Obstet Gynecol 121: 233-7.
60. OSTREA E.M., CHAVEZ C.J., STRAUSS M.E. (1976): A study of factors that influence the severity of narcotic withdrawal. J Pediatr 88: 642-645.
61. PETRY, N.M. (2000): A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend 58:9-25.
62. PETRY, N.M., TEDFORD, J., MARTIN, B. (2001): Reinforcing compliance with non-drug related activities, J Subst Abuse Treat 20: 33-44.
63. PHIBBS, C.S., BATERMAN, D.A., SCHWARTZ, R.M. (1991): The neonatal costs of maternal cocaine use. JAMA 226: 1521-1526.
64. REISINGER M., ET AL. (1995): Treatment of four pregnant heroin addicts with buprenorphine: history and outcome. In Harris L.S., Ed.. Problems of Drug Dependence, NIDA Research Monograph No. 162. U.S. Government Printing Office, Washington, D.C. p. 261.
65. ROSEN T.S., PIPPENGER C.E. (1976): Pharmacologic observations on the neonatal withdrawal syndrome. J Pediatr 88: 1044-1048.
66. SERACINI, A.M., NUNES, E.V., SPANO, C., TROSS, S. (1997): Achieving abstinence in perinatal cocaine-dependent women: a contingency management approach. In Harris, L.S., Ed. Problems of Drug Dependence. NIDA Research Monograph No. 174, NIH Publication no. 97-4236. U.S. Government Printing Office, Washington, DC. pp. 261.
67. SHAW N.J., MCIVOR L. (1994): Neonatal abstinence syndrome after material methadone treatment. Arch Dis Child 71: F203-205.
68. STIMMEL B., GOLDBERG J., REISMAN A., MURPHY R.J., TEETS K. (1982-83): Fetal outcome in narcotic-dependent women: the importance of the type of maternal narcotic used. Am J Drug Alcohol Abuse 9: 383-395.
69. STRAUSS M.E., ANDRESEKO M., STRYKER J.C., ET AL. (1976): Relationship of neonatal withdrawal to maternal methadone dose. Am J Drug Alcohol Abuse 3: 339-345.
70. SUFFET F., BROTMAN R. (1984): A comprehensive care program for pregnant addicts: obstetrical, neonatal, and child development outcomes. Intern J Addict 19: 199-219.
71. SVIKIS D.S., GOLDEN A., HUGGINS G., PICKENS R.W., MCCAUL M.E., VELEZ M., ROSENDALE T., BROONER R., GAZAWAY P., STITZER M., BALL C. (1997a): Cost-effectiveness of treatment for drug-abusing pregnant women. Drug Alcohol Depend 45: 105-113.
72. SVIKIS D.S., LEE J., HAUG N., STITZER M. (1997b): Attendance incentives for outpatient treatment: effects in methadone- and non-methadone-maintained pregnant drug dependent women. Drug Alcohol Depend 48: 33-41.
73. THAKUR N., KALTENBACH K., PEACOCK J., WEINER S., FINNEGAN L. (1990): The relationship between maternal methadone dose during pregnancy and infant outcome. Pediatr Res 28: 277A.
74. U.S. DEPT. OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTE ON DRUG ABUSE. National Pregnancy and Health Survey: Drug Use Among Women Delivering Live Births, (1992): [Computer file]. ICPSR version. Rockville, MD: Westat, Inc. [producer], (1996). Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], (2000).